APA (7th ed.) Citation

Tong, X., Le Pogam, S., Li, L., Haines, K., Piso, K., Baronas, V., . . . Nájera, I. (2014). In Vivo Emergence of a Novel Mutant L159F/L320F in the NS5B Polymerase Confers Low-Level Resistance to the HCV Polymerase Inhibitors Mericitabine and Sofosbuvir. The Journal of infectious diseases, 209(5), 668-675. https://doi.org/10.1093/infdis/jit562

Chicago Style (17th ed.) Citation

Tong, Xiao, et al. "In Vivo Emergence of a Novel Mutant L159F/L320F in the NS5B Polymerase Confers Low-Level Resistance to the HCV Polymerase Inhibitors Mericitabine and Sofosbuvir." The Journal of Infectious Diseases 209, no. 5 (2014): 668-675. https://doi.org/10.1093/infdis/jit562.

MLA (9th ed.) Citation

Tong, Xiao, et al. "In Vivo Emergence of a Novel Mutant L159F/L320F in the NS5B Polymerase Confers Low-Level Resistance to the HCV Polymerase Inhibitors Mericitabine and Sofosbuvir." The Journal of Infectious Diseases, vol. 209, no. 5, 2014, pp. 668-675, https://doi.org/10.1093/infdis/jit562.